Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H

Lake Street analyst Frank Takkinen notes that small cap healthcare remains range bound while larger cap indices continue to make all-time highs and presents investors with five “bargain bin” ideas for the second half that have solid fundamentals, trade below the comp group averages, grow double-digits, and have novel technologies that the firm sees supporting durable growth or a strategic takeout. The firm highlighted Artivion (AORT) with a $30 price target, Lensar (LNSR) with an $8 target, NeuroPace (NPCE) with a $20 target, Pulmonx (LUNG) with a $12 target and TELA Bio (TELA) with a $14 price target, all of which are Buy-rated.